XML 109 R89.htm IDEA: XBRL DOCUMENT v3.22.1
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Condensed Balance Sheets (Details) - USD ($)
$ / shares in Units, $ in Thousands
Dec. 31, 2021
Jun. 17, 2021
Jun. 03, 2021
Dec. 31, 2020
Dec. 31, 2019
Sep. 03, 2019
Jun. 13, 2019
Dec. 31, 2018
ASSETS                
Total assets $ 829,903     $ 843,068        
LIABILITIES AND SHAREHOLDERS’ EQUITY                
Common stock, $0.01 par value; 500,000,000 and 126,000,000 shares authorized as of December 31, 2021, and December 31, 2020, respectively; 73,194,171 and 61,321,424 shares issued and outstanding as of December 31, 2021, and December 31, 2020, respectively 732     613        
Accumulated other comprehensive income 31     78        
Accumulated deficit (33,266)     (23,288)        
Total shareholders’ equity 537,749     470,150 $ 469,873 $ 175,129 $ 0 $ 171,020
Total liabilities and shareholders’ equity $ 829,903     $ 843,068        
Preferred stock par value (in usd per share) $ 0.01 $ 0.01   $ 0.01        
Common stock shares authorized 500,000,000 500,000,000 1,000,000 126,000,000        
Common stock shares issued 73,194,171     61,321,424        
Common stock shares outstanding 73,194,171     61,321,424        
Parent                
ASSETS                
Investment in subsidiaries $ 546,372     $ 470,285        
Total assets 546,372     470,285        
LIABILITIES AND SHAREHOLDERS’ EQUITY                
Due to Affiliate 8,623     135        
Common stock, $0.01 par value; 500,000,000 and 126,000,000 shares authorized as of December 31, 2021, and December 31, 2020, respectively; 73,194,171 and 61,321,424 shares issued and outstanding as of December 31, 2021, and December 31, 2020, respectively 732     613        
Additional paid-in capital 570,252     492,747        
Accumulated other comprehensive income 31     78        
Accumulated deficit (33,266)     (23,288)        
Total shareholders’ equity 537,749     470,150        
Total liabilities and shareholders’ equity $ 546,372     $ 470,285